Grantee Research Project Results
Publications Details for Grant Number R826139
Studies of the Infectivity of Norwalk and Norwalk-like Viruses
Other Views
- All
Publications - Selected
Publication Types - Journal
Articles - Publications Submitted
After Final Report - Redisplay this page with
Reference Title, Journal, and Author Columns - Display this Page
in RIS Format
| Reference Type | Citation | Progress Report Year | Document Sources |
|---|---|---|---|
| Journal Article | Baric RS, Yount B, Lindesmith L, Harrington PR, Greene SR, Tseng F-C, Davis N, Johnston RE, Klapper DG, Moe CL. Expression and self-assembly of Norwalk virus capsid protein from Venezuelan equine encephalitis virus replicons. Journal of Virology 2002;76(6):3023-3030. |
R826139 (Final) |
|
| Journal Article | Brinker JP, Blacklow NR, Estes MK, Moe CL, Schwab KJ, Herrmann JE. Detection of Norwalk virus and other genogroup 1 human caliciviruses by a monoclonal antibody, recombinant-antigen-based immunoglobulin M capture enzyme immunoassay. Journal of Clinical Microbiology 1998;36(4):1064-1069. |
R826139 (Final) |
|
| Journal Article | Brinker JP, Blacklow NR, Jiang X, Estes MK, Moe CL, Herrmann JE. Immunoglobulin M antibody test to detect genogroup II Norwalk-like virus infection. Journal of Clinical Microbiology 1999;37(9):2983-2986. |
R826139 (Final) |
|
| Journal Article | Greene SR, Moe CL, Jaykus L-A, Cronin M, Grosso L, van Aarle P. Evaluation of the NucliSens® Basic Kit assay for detection of Norwalk virus RNA in stool specimens. Journal of Virological Methods 2003;108(1):123-131. |
R826139 (Final) |
|
| Journal Article | Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. Journal of Virology 2002;76(23):12335-12343. |
R826139 (Final) |
|
| Journal Article | Harrington PR, Yount B, Johnston RE, Davis N, Moe C, Baric RS. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. Journal of Virology 2002;76(2):730-742. |
R826139 (Final) |
|
| Journal Article | Harrington PR, Vinje J, Moe CL, Baric RS. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. Journal of Virology 2004;78(6):3035-3045. |
R826139 (Final) |
|
| Journal Article | Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R. Human susceptibility and resistance to Norwalk virus infection. Nature Medicine 2003;9(5):548-553. |
R826139 (Final) |
|
| Journal Article | Lindesmith L, Moe C, LePendu J, Frelinger JA, Treanor J, Baric RS. Cellular and humoral immunity following Snow Mountain virus challenge. Journal of Virology 2005;79(5):2900-2909. |
R826139 (Final) |
|
| Journal Article | LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 2006;24(24):5220-5234. |
R826139 (Final) |
|
| Journal Article | Moe CL, Sair A, Lindesmith L, Estes MK, Jaykus L-A. Diagnosis of Norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant Norwalk virus antigen. Clinical and Diagnostic Laboratory Immunology 2004;11(6):1028-1034. |
R826139 (Final) |
|
| Journal Article | Sair AI, D'Souza DH, Moe CL, Jaykus L-A. Improved detection of human enteric viruses in foods by RT-PCR. Journal of Virological Methods 2002;100(1-2):57-69. |
R826139 (Final) |
|
| Journal Article | Teunis PFM, Moe CL, Liu P, Miller SE, Lindesmith L, Baric RS, Le Pendu J, Calderon RL. Norwalk virus: how infectious is it? Journal of Medical Virology 2008;80(8):1468-1476. |
R826139 (Final) |
|
| Meeting | Moe C, Rhodes D, Pusek S, Tseng F, Heizer W, Kapoor C, Gilliam B, Harb M, Stewart P, Miller S, Sobsey M, Herrmann J, Blacklow N, Calderon R. Determination of Norwalk virus dose-response in human volunteers. In: Abstracts of the 98th Annual Meeting of the American Society for Microbiology, Atlanta, GA, May 1998. |
R826139 (2000) |
not available |
| Presentation | Baric RS, Yount B, Tseng F, Greene SR, Moe C. Expression and self-assembly of calicivirus capsids with alphavirus vectors. Presented at the 19th Annual Meeting of the American Society for Virology, Fort Collins, CO, July 2000. |
R826139 (2000) R826139 (Final) |
not available |
| Presentation | Greene SR, Moe CL, Jaykus L, Cronin M. Evaluation of a rapid method for detection of Norwalk virus RNA. Presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 1999. |
R826139 (Final) |
not available |
| Presentation | Greene SR, Moe C, Jaykus L-A, Grosso L, Cronin M. Analysis of a nucleic acid sequence-based amplification assay for detection of Norwalk RNA. Presented at the Clinical Virology Symposium, Clearwater, FL, April 2001. |
R826139 (Final) |
not available |
| Presentation | Harrington PR, Yount B, Moe C, Baric RS. Systemic, mucosal and heterotypic immune responses in mice inoculated with Venezuelan Equine Encephalitis replicons that express Norwalk virus-like particles. Presented at the 20th Annual Meeting of the American Society for Virology, Madison, WI, July 2001. |
R826139 (Final) |
not available |
| Presentation | Harrington PR, Yount B, Moe C, Baric RS. Expression and self-assembly of Norwalk-like virus capsid proteins in mammalian cells using Venezuelan Equine Encephalitis replicons and immune induction in mice. Presented at the 7th Southeastern Regional Virology Conference, Atlanta, GA, March 2002. |
R826139 (Final) |
not available |
| Presentation | Lindesmith LC, Moe CL, LePendu J, Marionneau S, Ruvoen N, Jiang J, Baric RS. Determinants of susceptibility and protective immunity to Norwalk virus infection. Presented at the 7th Southeastern Regional Virology Conference, Atlanta, GA, March 2002. |
R826139 (Final) |
not available |
| Presentation | Lindesmith L, Moe CL, Stewart PW, Baric RS. Evidence of a protective mucosal immune response to Norwalk virus infection. Presented at the 20th Annual Meeting of the American Society for Virology, Madison, WI, July 2001. |
R826139 (Final) |
not available |
| Presentation | Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, LePendu J, Baric R. Determinants of susceptibility and protective immunity to Norwalk virus infection. Presented at the 12th International Congress of Virology, Paris, France, July 2002. |
R826139 (Final) |
not available |
| Presentation | Lindesmith L, Moe C, LePendu J, Marionneau S, Ruvoen N, Jiang J, Baric R. Determinants of susceptibility and protective immunity to Norwalk virus infection. Presented at the 21st Annual Meeting of the American Society for Virology, Lexington, KY, July 2002. |
R826139 (Final) |
not available |
| Presentation | Moe CL. Studies of the infectivity of Norwalk and Norwalk-like viruses. Presented at the 1998 Drinking Water Progress Review Workshop, Arlington, VA, December 8-9, 1998. |
R826139 (2000) R826139 (Final) |
not available |
| Presentation | Moe CL, Sobsey MD, Stewart PW, Crawford-Brown D. Estimating the risk of human calicivirus infection from drinking water. Poster P4-6 presented at the First International Calicivirus Workshop, Atlanta, GA, March 1999. |
R826139 (2000) R826139 (Final) |
not available |
| Presentation | Moe CL. Dose-response relationships of Norwalk virus from human challenge studies. Presented that 87th Annual Meeting of the International Association for Food Protection, Atlanta, GA, August 2000. |
R826139 (2000) R826139 (Final) |
not available |
| Presentation | Moe CL, Rhodes D, Pusek S, Stewart P, Tseng F, Heizer W, Kapoor C, Gilliam B, Harb M, Levine B, Miller S, Sobsey M, Herrmann J, Blacklow N, Calderon R. Norwalk virus dose-response. Presented at the WHO Workshop on Hazard Characterization of Pathogens in Food and Water, Bilthoven, The Netherlands, June 2000. |
R826139 (2000) R826139 (Final) |
not available |
| Presentation | Moe CL, Lindesmith L, Baric RS, Stewart P, Heizer W, Frelinger JA. Studies of the infectivity of Norwalk and Norwalk-like viruses. Presented at the STAR Drinking Water Progress Review Meeting, U.S. Environmental Protection Agency, Silver Spring, MD, February 2001. |
R826139 (2000) R826139 (Final) |
not available |
| Presentation | Moe CL, Lindesmith L. Caliciviruses and host genetic factors-defining susceptibility in microbial risk assessment:a dialogue. Presented at George Washington University, Washington, DC, June 2001. |
R826139 (Final) |
not available |
| Presentation | Moe CL. Studies on the infectivity of Norwalk and Norwalk-like viruses. Presented at the Health Effects Stakeholder Meeting for the Stage 2 DBPR and LT2ESWTR, U.S. Environmental Protection Agency, Washington, DC, February 1999. |
R826139 (2000) R826139 (Final) |
not available |
| Presentation | Moe C, Rhodes D, Pusek S, eds. Determination of Norwalk virus dose-response in human volunteers. Published abstract of poster presented at the 98th Annual Meeting of the American Society for Microbiology, Atlanta, GA, May 1998. |
R826139 (Final) |
not available |
| Presentation | Moe C, Rhodes D, Pusek S eds. Determination of Norwalk virus dose-response in human volunteers. Presented at the Water Quality and Technology Conference, San Diego, CA, November 1998. |
R826139 (Final) |
not available |
| Presentation | Moe C, Baric R. New insights into host susceptibility and immune response to Norwalk virus infection. Presented at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, August 2002. |
R826139 (Final) |
not available |
| Presentation | Moe C, Rhodes D, Pusek S, Tseng F, Heizer W, Kapoor C, Gilliam B, Harb M, Stewart P, Miller S, Sobsey M, Herrmann J, Blacklow N, Calderon R. Determination of Norwalk virus dose-response in human volunteers. Poster #C-384 presented at the 98th Annual Meeting of the American Society for Microbiology, Atlanta, GA, May 1998. |
R826139 (2000) |
not available |
| Presentation | Moe C, Rhodes D, Pusek S, Tseng F, Heizer W, Kapoor C, Gilliam B, Stewart P, Harb M, Miller S, Sobsey M, Herrmann J, Blacklow N, Calderon R. Determination of Norwalk virus dose-response in human volunteers. Presented at the Water Quality and Technology Conference, San Diego, CA, November 1998. |
R826139 (2000) |
not available |
| Presentation | Rockx B, Bogers W, Heeney J, Estes M, Jiang X, Moe C, Koopmans M. Experimental infection of common marmosets with Norwalk virus. Presented at the 20th Annual Meeting of the American Society for Virology, Madison, WI, July 2001. |
R826139 (Final) |
not available |
| Presentation | Sair AI, Moe CL, Estes MK, Jaykus L. Diagnosis of Norwalk virus infection by detection of salivary antibodies to recombinant Norwalk virus antigen by indirect enzyme-linked immunosorbent assay. Poster # C-43 presented at the 100th Annual Meeting of the American Society for Microbiology, Los Angeles, CA, May 2000. |
R826139 (2000) R826139 (Final) |
not available |
| Proceedings | Moe CL. Studies of the infectivity of Norwalk and Norwalk-like viruses. In: Proceedings of the 1998 Drinking Water Progress Review Workshop for the 1995/1998 STAR Grants. EPA 600/R-98/162, November 1998, p. 32. |
R826139 (2000) |
not available |
The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.